Sort   by:  
 Page size 
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownCardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Not available
S-EPMC9004319 | biostudies-literature
UnknownLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.
Not available
S-EPMC3771688 | biostudies-literature
UnknownGenome-wide association analysis identifies three new breast cancer susceptibility loci.
Not available
S-EPMC3653403 | biostudies-literature
UnknownAggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Not available
S-EPMC9878779 | biostudies-literature
UnknownLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.
Not available
S-EPMC4661791 | biostudies-literature
UnknownGenome-wide association studies identify four ER negative-specific breast cancer risk loci.
Not available
S-EPMC3771695 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
Sort   by:  
 Page size